ESR1 and breast carcinoma: Hagrass et al. studied a cohort of Egyptian women and discovered that promoter hypermethylation of the estrogen receptor alpha (ERα) was most frequently detected in individuals with breast cancer when tested in the serum of 120 patients with breast cancer compared to 100 benign breast lesions [77].